| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LUNG | Common Stock | Sale | -$36.6K | -1K | -4.07% | $36.59 | 23.6K | Aug 19, 2021 | See footnote | F1, F2 |
| transaction | LUNG | Common Stock | Sale | -$916K | -25K | -2.07% | $36.63 | 1.18M | Aug 19, 2021 | Direct | F3, F4, F5 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. |
| F2 | The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. |
| F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $37.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F5 | Includes 57 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021. |